• 1. Evidence Based Social Science Research Center/Health Technology Assessment Center, School of Public Health, Lanzhou University, Lanzhou 730000, P. R. China;
  • 2. Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China;
  • 3. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, P. R. China;
  • 4. School of Health Sciences, Wuhan University, Wuhan 430062, P. R. China;
LU Cuncun, Email: cuncunlu2017@163.com; LI Xiuxia, Email: lixiuxia@lzu.edu.cn
Export PDF Favorites Scan Get Citation

Clinical prediction models typically utilize a combination of multiple variables to predict individual health outcomes. However, multiple prediction models for the same outcome often exist, making it challenging to determine the suitable model for guiding clinical practice. In recent years, an increasing number of studies have evaluated and summarized prediction models using the systematic review/meta-analysis method. However, they often report poorly on critical information. To enhance the reporting quality of systematic reviews/meta-analyses of prediction models, foreign scholars published the TRIPOD-SRMA reporting guideline in BMJ in March 2023. As the number of such systematic reviews/meta-analyses is increasing rapidly domestically, this paper interprets the reporting guideline with a published example. This study aims to assist domestic scholars in better understanding and applying this reporting guideline, ultimately improving the overall quality of relevant research.

Citation: WANG Ziyi, LU Cuncun, ZHANG Jinglei, HUANG Jiayi, LIU Wendi, SHANG Wenru, CHEN Zijia, CUI Lu, ZHAO Xiaoxiao, HU Xiaoye, YANG Kehu, LI Xiuxia. Interpretation of checklist for transparent reporting of multivariable prediction models for individual prognosis or diagnosis tailored for systematic reviews and meta-analyses (TRIPOD-SRMA). Chinese Journal of Evidence-Based Medicine, 2024, 24(2): 202-210. doi: 10.7507/1672-2531.202308041 Copy

  • Previous Article

    Quality evaluation of studies on the core outcome set of Chinese medicine
  • Next Article

    Deliberative processes for health technology assessment: interpretation of the guideline from the Joint HTAi/ISPOR Task Force